The Adaptate Biotherapeutics brand, founded in 2019 (Canada), from 439 sister brands and 4654 competing brands. The Adaptate Biotherapeutics brand is owned by Takeda Pharmaceutical, a company listed in Francfort. The International Securities Identification Number (ISIN) of Takeda Pharmaceutical is JP3463000004. Adaptate Biotherapeutics is part of the Drug Manufacturers - Specialty & Generic activity sector.

Share price and profitability of the share Takeda Pharmaceutical (Adaptate Biotherapeutics)

Buy Takeda Pharmaceutical share with Your capital is subject to risk.

Investment simulator :

Amount invested EUR 25.63

Portfolio valuation
Takeda Pharmaceutical (Adaptate Biotherapeutics) over 5 years* EUR 16.36

Stock market history Takeda Pharmaceutical (Adaptate Biotherapeutics)

Top Popularity Web